Lowest Price Guaranteed
Slides
187
Last Updated
July 2026
View Count
5523
1. BACKGROUND
1.1. Context
1.2. Project Objectives
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Overview of Inflammatory Bowel Disease
6.2. Type of Inflammatory Bowel Disease
6.3. Factors Contributing to Inflammatory Bowel Disease
6.4. Inflammatory Bowel Treatment and Management
6.5. Future Perspectives
7. MARKET LANDSCAPE OF INFLAMMTORY BOWEL DISEASE TREATMENT THERAPY PROGRAMS
7.1. Methodology and Key Parameters
7.2. Inflammatory Bowel Disease Treatment Therapy Programs: Market Landscape
7.2.1. Analysis by Stage of Development
7.2.2. Analysis by Clinical Stage of Development
7.2.3. Analysis by Type of Molecule
7.2.4. Analysis by Type of Biologic
7.2.5. Analysis by Type of Therapy
7.2.6. Analysis by Drug Frequency
7.2.7. Analysis by Route of Administration
7.2.8. Analysis by Target Pathway
7.2.9. Analysis by Target Patient Population
7.2.10. Analysis by Type of Inflammatory Bowel Disease
7.2.11. Analysis by Year of Establishment
7.2.12. Analysis by Company Size
7.2.13. Analysis by Location of Headquarters
7.2.14. Most Active Players: Number of Therapy Programs
8. CLINICAL COMMERCIAL ATTRACTIVENESS
8.1. Methodology and Key Parameters
8.2. Key Parameters and Scoring
8.3. Phase III Drugs Targeting Inflammatory Bowel Disease
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. AbbVie
9.2.1. Drug Portfolio
9.2.2. Key Initiatives
9.3. Athos Therapeutics
9.4. Eli Lilly and Company
9.5. Janssen Biotech
9.6. Pfizer
9.7. Roche
9.8. Sanofi
9.9. Spyre Therapeutics
9.10. Takeda
10. CLINICAL TRIAL ANALYSIS
10.1. Methodology and Key Parameters
10.2. Inflammatory Bowel Disease Treatment Therapy Programs: Clinical Trial Analysis
10.2.1. Analysis by Trial Registration Year
10.2.2. Analysis by Trial Status
10.2.3. Analysis by Trial Registration Year and Trial Status
10.2.4. Analysis by Trial Registration Year and Patients Enrolled
10.2.5. Analysis by Trial Phase
10.2.6. Analysis by Trial Registration Year and Trial Phase
10.2.7. Analysis of Patients Enrolled by Trial Phase
10.2.8. Analysis by Study Design
10.2.8.1. Analysis by Design Masking
10.2.8.2. Analysis by Intervention Model
10.2.8.3. Analysis by Trial Purpose
10.2.8.4. Analysis by Allocation
10.2.9. Analysis by Target Patient Population
10.2.10. Most Active Sponsor / Collaborator: Analysis by Number of Registered Trials
10.2.10.1. Analysis by Leading Industry Players
10.2.10.2. Analysis by Leading Non-Industry Players
10.2.11. Analysis by Geography
10.2.11.1. Analysis of Clinical Trials by Trial Status and Geography
10.2.11.2. Analysis of Patients Enrolled by Trial Status and Geography
11. DRUG FAILURE ANALYSIS
11.1. Methodology and Key Parameters
11.2. Inflammatory Bowel Disease Treatment Therapy Programs: Drug Failure Analysis
11.2.1. Analysis by Trial Phase
11.2.2. Analysis by Trial Status and Discontinuation
11.2.3. Analysis by Reason for Drug Discontinuation
11.2.4. Analysis by Study Start Year and Year of Termination
11.2.5. Analysis by Type of Inflammatory Bowel Disease
11.2.6. Analysis by Type of Sponsor / Collaborator
12. MARKET IMPACT ANALYSIS
12.1. Market Drivers
12.2. Market Restraints
12.3. Market Opportunities
12.4. Market Challenges
13. GLOBAL INFLAMMATORY BOWEL DISEASE TREATMENT MARKET
13.1. Key Assumptions and Methodology
13.2. Global Inflammatory Bowel Disease Treatment Market, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
13.2.1. Multivariate Scenario Analysis
13.2.1.1. Conservative Scenario
13.2.1.2. Optimistic Scenario
13.3. Key Market Segments
14. INFLAMMATORY BOWEL DISEASE TREATMENT MARKET, BY DRUG CLASS
14.1. Key Assumptions and Methodology
14.2. Inflammatory Bowel Disease Treatment Market : Distribution by Drug Class
14.2.1. Inflammatory Bowel Disease Treatment Market for Biologics, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
14.2.2. Inflammatory Bowel Disease Treatment Market for Amino salicylates, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
14.2.3. Inflammatory Bowel Disease Treatment Market for Antibiotics, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
14.2.4. Inflammatory Bowel Disease Treatment Market for Corticosteroids, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
14.2.5. Inflammatory Bowel Disease Treatment Market for Immunomodulators, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
14.2.6. Inflammatory Bowel Disease Treatment Market for Others, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
14.3. Data Triangulation and Validation
15. INFLAMMATORY BOWEL DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
15.1. Key Assumptions and Methodology
15.2. Inflammatory Bowel Disease Treatment Market : Distribution by Route of Administration
15.2.1. Inflammatory Bowel Disease Treatment Market for Subcutaneous Route, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
15.2.2. Inflammatory Bowel Disease Treatment Market for Intravenous Route, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
15.2.3. Inflammatory Bowel Disease Treatment Market for Oral Route, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
15.3. Data Triangulation and Validation
16. INFLAMMATORY BOWEL DISEASE TREATMENT MARKET, BY TARGET INDICATION
16.1. Key Assumptions and Methodology
16.2. Inflammatory Bowel Disease Treatment Market: Distribution by Target Indication
16.2.1. Inflammatory Bowel Disease Treatment Market for Ulcerative Colitis, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
16.2.2. Inflammatory Bowel Disease Treatment Market for Crohn’s Disease, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
16.3. Data Triangulation and Validation
17. INFLAMMATORY BOWEL DISEASE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
17.1. Key Assumptions and Methodology
17.2. Inflammatory Bowel Disease Treatment Market : Distribution by Distribution Channel
17.2.1. Inflammatory Bowel Disease Treatment Market for Hospital Pharmacies, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
17.2.2. Inflammatory Bowel Disease Treatment Market for Retail Pharmacies, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
17.2.3. Inflammatory Bowel Disease Treatment Market for Online Pharmacies, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
17.3. Data Triangulation and Validation
18. INFLAMMATORY BOWEL DISEASE TREATMENT MARKET, BY GEOGRAPHICAL REGIONS
18.1. Key Assumptions and Methodology
18.2. Inflammatory Bowel Disease Treatment Market : Distribution by Geographical Regions
18.2.1. Inflammatory Bowel Disease Treatment Market in North America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.1.1. Inflammatory Bowel Disease Treatment Market in the US: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.1.2. Inflammatory Bowel Disease Treatment Market in Canada: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2. Inflammatory Bowel Disease Treatment Market in Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2.1. Inflammatory Bowel Disease Treatment Market in Germany: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2.2. Inflammatory Bowel Disease Treatment Market in the UK: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2.3. Inflammatory Bowel Disease Treatment Market in France: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2.4. Inflammatory Bowel Disease Treatment Market in Spain: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2.5. Inflammatory Bowel Disease Treatment Market in Italy: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.2.6. Inflammatory Bowel Disease Treatment Market in Rest of Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3. Inflammatory Bowel Disease Treatment Market in Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3.1. Inflammatory Bowel Disease Treatment Market in China: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3.2. Inflammatory Bowel Disease Treatment Market in Japan: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3.3. Inflammatory Bowel Disease Treatment Market in Australia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3.4. Inflammatory Bowel Disease Treatment Market in India: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3.5. Inflammatory Bowel Disease Treatment Market in South Korea: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.3.6. Inflammatory Bowel Disease Treatment Market in Rest of Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.4. Inflammatory Bowel Disease Treatment Market in Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.4.1. Inflammatory Bowel Disease Treatment Market in Israel: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.4.2. Inflammatory Bowel Disease Treatment Market in Saudi Arabia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.4.3. Inflammatory Bowel Disease Treatment Market in United Arab Emirates: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.4.4. Inflammatory Bowel Disease Treatment Market in Egypt: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.5. Inflammatory Bowel Disease Treatment Market in Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.5.1. Inflammatory Bowel Disease Treatment Market in Brazil: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.5.2. Inflammatory Bowel Disease Treatment Market in Mexico: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.2.5.3. Inflammatory Bowel Disease Treatment Market in Argentina: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
18.3. Revenue Shift Analysis: Geographical Regions
18.4. Penetration-Growth (P-G) Matrix: Geographical Regions
18.5. Data Triangulation and Validation
19. CONCLUSION
20. APPENDIX I: TABULATED DATA
21. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 2.3 Research Methodology: Robust Quality Control
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Market Assessment Framework
Figure 3.3 Market Dynamics: Example List of Parameters
Figure 5.1 Executive Summary: Market Landscape
Figure 5.2 Executive Summary: Market Trends
Figure 5.3 Executive Summary: Market Forecast and Opportunity Analysis
Figure 6.1 Inflammatory Bowel Treatment and Management
Figure 7.1 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Stage of Development
Figure 7.2 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Clinical Stage of Development
Figure 7.3 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Molecule
Figure 7.4 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Biologic
Figure 7.5 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Therapy
Figure 7.6 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Drug Frequency
Figure 7.7 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Route of Administration
Figure 7.8 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Target Pathway
Figure 7.9 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Target Patient Population
Figure 7.10 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Inflammatory Bowel Disease
Figure 7.11 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Year of Establishment
Figure 7.12 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Company Size
Figure 7.13 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Location of Headquarters
Figure 7.14 Inflammatory Bowel Disease Treatment Therapy Programs: Most Active Players: Number of Therapy Programs
Figure 8.1 Phase III Drugs Targeting Inflammatory Bowel Disease
Figure 10.1 Clinical Trial Analysis: Distribution by Trial Registration Year
Figure 10.2 Clinical Trial Analysis: Distribution by Trial Status
Figure 10.3 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Figure 10.4 Clinical Trial Analysis: Distribution by Trial Registration Year and Patients Enrolled
Figure 10.5 Clinical Trial Analysis: Distribution by Trial Phase
Figure 10.6 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Phase
Figure 10.7 Clinical Trial Analysis: Distribution by Patients Enrolled by Trial Phase
Figure 10.8 Clinical Trial Analysis: Distribution by Design Masking
Figure 10.9 Clinical Trial Analysis: Distribution by Intervention Model
Figure 10.10 Clinical Trial Analysis: Distribution by Trial Purpose
Figure 10.11 Clinical Trial Analysis: Distribution by Allocation
Figure 10.12 Clinical Trial Analysis: Distribution by Target Patient Population
Figure 10.13 Most Active Industry Players: Distribution by Number of Clinical Trials
Figure 10.14 Most Active Non-Industry Players: Distribution by Number of Clinical Trials
Figure 10.15 Clinical Trial Analysis: Distribution of Clinical Trials by Trial Status and Geography
Figure 10.16 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Status and Geography
Figure 11.1 Drug Failure Analysis: Distribution by Trial Phase
Figure 11.2 Drug Failure Analysis: Distribution by Trial Status and Discontinuation
Figure 11.3 Drug Failure Analysis: Distribution by Reason for Drug Discontinuation
Figure 11.4 Drug Failure Analysis: Distribution by Study Start Year and Year of Termination
Figure 11.5 Drug Failure Analysis: Distribution by Type of Inflammatory Bowel Disease
Figure 11.6 Drug Failure Analysis: Distribution by Type of Type of Sponsor / Collaborator
Figure 13.1 Global Inflammatory Bowel Disease Treatment Market, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 13.2 Global Inflammatory Bowel Disease Treatment Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Billion)
Figure 13.3 Global Inflammatory Bowel Disease Treatment Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Billion)
Figure 14.1 Inflammatory Bowel Disease Treatment Market for Biologics, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 14.2 Inflammatory Bowel Disease Treatment Market for Amino Salicylates, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 14.3 Inflammatory Bowel Disease Treatment Market for Antibiotics, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 14.4 Inflammatory Bowel Disease Treatment Market for Corticosteroids, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 14.5 Inflammatory Bowel Disease Treatment Market for Immunomodulators, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 14.6 Inflammatory Bowel Disease Treatment Market for Others, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 15.1 Inflammatory Bowel Disease Treatment Market for Subcutaneous Route, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 15.2 Inflammatory Bowel Disease Treatment Market for Intravenous Route, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 15.3 Inflammatory Bowel Disease Treatment Market for Oral Route, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 16.1 Inflammatory Bowel Disease Treatment Market for Ulcerative Colitis, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 16.2 Inflammatory Bowel Disease Treatment Market for Crohn’s Disease, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 17.1 Inflammatory Bowel Disease Treatment Market for Hospital Pharmacies, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 17.2 Inflammatory Bowel Disease Treatment Market for Retail Pharmacies, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 17.3 Inflammatory Bowel Disease Treatment Market for Online Pharmacies, Historical Trends (since 2023) and Forecasted Estimates (till 2035)
Figure 18.1 Inflammatory Bowel Disease Treatment Market in North America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.2 Inflammatory Bowel Disease Treatment Market in the US: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.3 Inflammatory Bowel Disease Treatment Market in Canada: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.4 Inflammatory Bowel Disease Treatment Market in Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.5 Inflammatory Bowel Disease Treatment Market in Germany: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.6 Inflammatory Bowel Disease Treatment Market in the UK: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.7 Inflammatory Bowel Disease Treatment Market in France: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.8 Inflammatory Bowel Disease Treatment Market in Spain: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.9 Inflammatory Bowel Disease Treatment Market in Italy: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.10 Inflammatory Bowel Disease Treatment Market in Rest of Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.11 Inflammatory Bowel Disease Treatment Market in Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.12 Inflammatory Bowel Disease Treatment Market in China: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.13 Inflammatory Bowel Disease Treatment Market in Japan: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.14 Inflammatory Bowel Disease Treatment Market in Australia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.15 Inflammatory Bowel Disease Treatment Market in India: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.16 Inflammatory Bowel Disease Treatment Market in South Korea: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.17 Inflammatory Bowel Disease Treatment Market in Rest of Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.18 Inflammatory Bowel Disease Treatment Market in Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.19 Inflammatory Bowel Disease Treatment Market in Israel: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.20 Inflammatory Bowel Disease Treatment Market in Saudi Arabia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.21 Inflammatory Bowel Disease Treatment Market in United Arab Emirates: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.22 Inflammatory Bowel Disease Treatment Market in Egypt: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.23 Inflammatory Bowel Disease Treatment Market in Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.24 Inflammatory Bowel Disease Treatment Market in Brazil: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.25 Inflammatory Bowel Disease Treatment Market in Mexico: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.26 Inflammatory Bowel Disease Treatment Market in Argentina: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
Figure 18.27 Revenue Shift Analysis: Geographical Regions
Figure 18.28 Penetration-Growth (P-G) Matrix: Geographical Regions
Table 7.1 Inflammatory Bowel Disease Therapies: List of Inflammatory Bowel Disease Therapy Programs
Table 7.2 Inflammatory Bowel Disease Therapies: Information on Route of Administration, Target Pathway, Target Patient Population and Type of Inflammatory Bowel Disease
Table 7.3 Inflammatory Bowel Disease Treatment Therapy Program Developers: List of Inflammatory Bowel Disease Treatment Therapy Program Developers
Table 10.1 Inflammatory Bowel Disease Treatment: List of Clinical Trials, Till 2026
Table 11.1 Inflammatory Bowel Disease Treatment Therapy Programs: List of Discontinued Trials
Table 20.1 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Stage of Development
Table 20.2 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Clinical Stage of Development
Table 20.3 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Molecule
Table 20.4 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Biologic
Table 20.5 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Therapy
Table 20.6 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Drug Frequency
Table 20.7 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Route of Administration
Table 20.8 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Target Pathway
Table 20.9 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Target Patient Population
Table 20.10 Inflammatory Bowel Disease Treatment Therapy Programs: Distribution by Type of Inflammatory Bowel Disease
Table 20.11 Inflammatory Bowel Disease Treatment Therapy Program Developers: Distribution by Year of Establishment
Table 20.12 Inflammatory Bowel Disease Treatment Therapy Program Developers: Distribution by Company Size
Table 20.13 Inflammatory Bowel Disease Treatment Therapy Program Developers: Distribution by Location of Headquarters
Table 20.14 Most Active Players: Distribution by Number of Therapy Programs
Table 20.15 Clinical Trial Analysis: Distribution by Trial Registration Year
Table 20.16 Clinical Trial Analysis: Distribution by Trial Status
Table 20.17 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Table 20.18 Clinical Trial Analysis: Distribution by Trial Registration Year and Number of Patients Enrolled
Table 20.19 Clinical Trial Analysis: Distribution by Trial Phase
Table 20.20 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Phase
Table 20.21 Clinical Trial Analysis: Distribution of Number of Patients Enrolled by Trial Phase
Table 20.22 Clinical Trial Analysis: Distribution by Type of Design Masking
Table 20.23 Clinical Trial Analysis: Distribution by Type of Intervention Model
Table 20.24 Clinical Trial Analysis: Distribution by Trial Purpose
Table 20.25 Clinical Trial Analysis: Distribution by Type of Allocation
Table 20.26 Clinical Trial Analysis: Distribution by Target Patient Population
Table 20.27 Most Active Industry Players: Distribution by Number of Clinical Trials
Table 20.28 Most Active Non-Industry Players: Distribution by Number of Clinical Trials
Table 20.29 Clinical Trial Analysis: Distribution of Clinical Trials by Trial Status and Geography
Table 20.30 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Status and Geography
Table 20.31 Drug Failure Analysis: Distribution by Phase of Discontinuation
Table 20.32 Drug Failure Analysis: Distribution by Status of Discontinuation
Table 20.33 Drug Failure Analysis: Distribution by Reason of Drug Discontinuation
Table 20.34 Drug Failure Analysis: Distribution by Study Start Year and Year of Discontinuation
Table 20.35 Drug Failure Analysis: Distribution by Type of Inflammatory Bowel Disease
Table 20.36 Drug Failure Analysis: Distribution by Type of Sponsor / Collaborator
Table 20.37 Global Inflammatory Bowel Disease Treatment Market, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.38 Global Inflammatory Bowel Disease Treatment Market: Distribution by Drug Class
Table 20.39 Inflammatory Bowel Disease Treatment Market for Biologics, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.40 Inflammatory Bowel Disease Treatment Market for Amino salicylates, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.41 Inflammatory Bowel Disease Treatment Market for Antibiotics, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.42 Inflammatory Bowel Disease Treatment Market for Corticosteroids, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.43 Inflammatory Bowel Disease Treatment Market for Immunomodulators, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.44 Inflammatory Bowel Disease Treatment Market for Others, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.45 Inflammatory Bowel Disease Treatment Market: Distribution by Route of Administration
Table 20.46 Inflammatory Bowel Disease Treatment Market for Subcutaneous Route, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.47 Inflammatory Bowel Disease Treatment Market for Intravenous Route, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.48 Inflammatory Bowel Disease Treatment Market for Oral Route, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.49 Inflammatory Bowel Disease Treatment Market: Distribution by Target Indication
Table 20.50 Inflammatory Bowel Disease Treatment Market for Ulcerative Colitis, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.51 Inflammatory Bowel Disease Treatment Market for Crohn’s Disease, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.52 Inflammatory Bowel Disease Treatment Market: Distribution by Distribution Channel
Table 20.53 Inflammatory Bowel Disease Treatment Market for Hospital Pharmacy, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.54 Inflammatory Bowel Disease Treatment Market for Retail Pharmacy, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.55 Inflammatory Bowel Disease Treatment Market for Online Pharmacy, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.56 Inflammatory Bowel Disease Treatment Market: Distribution by Geographical Regions
Table 20.57 Inflammatory Bowel Disease Treatment Market in North America, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.58 Inflammatory Bowel Disease Treatment Market in the US, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.59 Inflammatory Bowel Disease Treatment Market in Canada, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.60 Inflammatory Bowel Disease Treatment Market in Europe, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.61 Inflammatory Bowel Disease Treatment Market in Germany, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.62 Inflammatory Bowel Disease Treatment Market in the UK, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.63 Inflammatory Bowel Disease Treatment Market in France, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.64 Inflammatory Bowel Disease Treatment Market in Spain, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.65 Inflammatory Bowel Disease Treatment Market in Italy, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.66 Inflammatory Bowel Disease Treatment Market in Rest of Europe, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.67 Inflammatory Bowel Disease Treatment Market in Asia-Pacific, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.68 Inflammatory Bowel Disease Treatment Market in China, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.69 Inflammatory Bowel Disease Treatment Market in Japan, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.70 Inflammatory Bowel Disease Treatment Market in Australia, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.71 Inflammatory Bowel Disease Treatment Market in India, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.72 Inflammatory Bowel Disease Treatment Market in South Korea, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.73 Inflammatory Bowel Disease Treatment Market in Rest of Asia-Pacific, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.74 Inflammatory Bowel Disease Treatment Market in Middle East and Africa, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.75 Inflammatory Bowel Disease Treatment Market in Saudi Arabia, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.76 Inflammatory Bowel Disease Treatment Market in Israel, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.77 Inflammatory Bowel Disease Treatment Market in United Arab Emirates, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.78 Inflammatory Bowel Disease Treatment Market in Egypt, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.79 Inflammatory Bowel Disease Treatment Market in Latin America, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.80 Inflammatory Bowel Disease Treatment Market in Brazil, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.81 Inflammatory Bowel Disease Treatment Market in Mexico, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)
Table 20.82 Inflammatory Bowel Disease Treatment Market in Argentina, Historical Trends (2023-2025) and Forecasted Estimates (2026-2035): Conservative, Base and Optimistic Scenario (USD Billion)